glycine has been researched along with Lymphoma, B-Cell in 9 studies
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both cell line-derived OCI-Ly10 and primary human lymphoma-derived PHTX22L xenograft models of diffuse large B-cell lymphoma were used to evaluate the pharmacodynamics and antitumor effects of MLN2238 and bortezomib." | 3.77 | Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. ( Bannerman, B; Bano, K; Berger, AJ; Bolen, JB; Bradley, DP; Carsillo, M; Donelan, J; Fitzgerald, M; Hales, P; Janz, S; Kupperman, E; Lee, EC; Li, P; Li, Z; Liu, R; Manfredi, M; Neppalli, VT; Pickard, M; Silva, MD; Subakan, O; Tayber, O; Terkelsen, J; Van Ness, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, S | 1 |
| Kuravi, S | 1 |
| Alleboina, S | 1 |
| Mudduluru, G | 1 |
| Jensen, RA | 1 |
| McGuirk, JP | 1 |
| Balusu, R | 1 |
| Roschewski, M | 1 |
| Farooqui, M | 1 |
| Aue, G | 1 |
| Wilhelm, F | 1 |
| Wiestner, A | 1 |
| Shen, J | 1 |
| Vallera, DA | 1 |
| Wagner, CR | 1 |
| Patel, KG | 1 |
| Swartz, JR | 1 |
| Lee, EC | 1 |
| Fitzgerald, M | 1 |
| Bannerman, B | 1 |
| Donelan, J | 1 |
| Bano, K | 1 |
| Terkelsen, J | 1 |
| Bradley, DP | 1 |
| Subakan, O | 1 |
| Silva, MD | 1 |
| Liu, R | 1 |
| Pickard, M | 1 |
| Li, Z | 1 |
| Tayber, O | 1 |
| Li, P | 1 |
| Hales, P | 1 |
| Carsillo, M | 1 |
| Neppalli, VT | 1 |
| Berger, AJ | 1 |
| Kupperman, E | 1 |
| Manfredi, M | 1 |
| Bolen, JB | 1 |
| Van Ness, B | 1 |
| Janz, S | 1 |
| McCabe, MT | 1 |
| Graves, AP | 1 |
| Ganji, G | 1 |
| Diaz, E | 1 |
| Halsey, WS | 1 |
| Jiang, Y | 1 |
| Smitheman, KN | 1 |
| Ott, HM | 1 |
| Pappalardi, MB | 1 |
| Allen, KE | 1 |
| Chen, SB | 1 |
| Della Pietra, A | 1 |
| Dul, E | 1 |
| Hughes, AM | 1 |
| Gilbert, SA | 1 |
| Thrall, SH | 1 |
| Tummino, PJ | 1 |
| Kruger, RG | 1 |
| Brandt, M | 1 |
| Schwartz, B | 1 |
| Creasy, CL | 1 |
| Shi, SR | 1 |
| Chaiwun, B | 1 |
| Young, L | 1 |
| Imam, A | 1 |
| Cote, RJ | 1 |
| Taylor, CR | 1 |
| Tong, X | 1 |
| Yalamanchili, R | 1 |
| Harada, S | 1 |
| Kieff, E | 1 |
| Seo, JK | 1 |
| Choi, SY | 1 |
| Kim, Y | 1 |
| Baek, SH | 1 |
| Kim, KT | 1 |
| Chae, CB | 1 |
| Lambeth, JD | 1 |
| Suh, PG | 1 |
| Ryu, SH | 1 |
1 trial available for glycine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
Topics: Aged; Antineoplastic Agents; Enzyme Inhibitors; Female; Glycine; Humans; Leukemia, Lymphocytic, Chro | 2013 |
8 other studies available for glycine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Targeted Therapy for EBV-Associated B-cell Neoplasms.
Topics: Antineoplastic Agents; Boron Compounds; Cell Line, Tumor; Epstein-Barr Virus Infections; G2 Phase Ce | 2019 |
Prosthetic Antigen Receptors.
Topics: Antibodies, Bispecific; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD3 Complex; Cell Deg | 2015 |
Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry.
Topics: Alanine; Alkynes; Animals; Antigens; Cell Line; Cell-Free System; Click Chemistry; CpG Islands; DNA; | 2011 |
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
Topics: Animals; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Glycin | 2011 |
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
Topics: Alanine; Amino Acid Sequence; Base Sequence; Binding Sites; Cell Line, Tumor; DNA Mutational Analysi | 2012 |
Antigen retrieval using pH 3.5 glycine-HCl buffer or urea solution for immunohistochemical localization of Ki-67.
Topics: Buffers; Cell Nucleus; Citrates; Formaldehyde; Glycine; Hydrochloric Acid; Hydrogen-Ion Concentratio | 1994 |
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Topics: Amino Acid Sequence; Antigens, Viral; Arginine; Base Sequence; Binding Sites; Burkitt Lymphoma; Cell | 1994 |
A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils.
Topics: Amino Acids; Biosensing Techniques; Calcium; Glycine; Hematopoietic Stem Cells; Humans; Hydrolysis; | 1997 |